Could an app help shield your brain from Alzheimer's-Linked drugs?

NCT ID NCT04121858

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app called Brain Safe can help older adults reduce their use of strong anticholinergic medications, which are linked to a higher risk of Alzheimer's disease. The trial enrolls 700 adults aged 60 and older who currently take such medications. Participants use either the Brain Safe app or a basic medication list app for 12 months, and researchers track changes in medication use and cognitive function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a smartphone app called Brain Safe that provides a medication list, personalized risk calculator, educational content, and a doctor's report
What this could lead to
If effective, this app could help older adults lower their exposure to certain medications that are linked to a higher risk of Alzheimer's disease.
What could go wrong
This is a behavioral intervention, not a drug, so its impact may be modest. The trial is relatively small and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IU Health

    Indianapolis, Indiana, 46202, United States

  • Indiana University

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.